Investing Profile

Jayson Punwani

InvestorVC
Managing Director at Abingworth
abingworth.com/team/jayson-pu...Menlo Park, California
Photo of Jayson Punwani, Managing Director at Abingworth

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4967 CONNECTIONS
UNC Kenan-Flagler Business School Network
28 CONNECTIONS
University of Utah Network
25 CONNECTIONS
University of North Carolina at Chapel Hill Network
16 CONNECTIONS
University of North Carolina at Chapel Hill Network
16 CONNECTIONS
cb
Abingworth Managing Director
$15.0M - $30.0M
$22.5M
4
$465M
CompanyStageDateRound SizeTotal Raised
Addition Therapeutics
Series ADec 2025$100M
$100M
Co-investors: Jennifer Lee (Pivotal bioVenture Partners), Peter Bisgaard (Nan Fung Life Sciences)
Xilio Therapeutics
Series CFeb 2021$95M
Series BMar 2020$100M
$330M
Co-investors: Andrew Hack (Bain Capital Ventures), Peter Dudek (M Ventures (Merck)), Mike Ross (SV Health Investors), Nancy Hong (San Diego Symphony), Jack Kenney (Estuary Capital Management, LP)
StrideBio
Series AJun 2018$16M
$98M
Co-investors: Karen Hong (De Novo Ventures), Shaan C. Gandhi (Longwood Fund)
Postdoctoral Research Associate University of North Carolina at Chapel HillPresent
Technology Development @ OTD University of North Carolina at Chapel HillPresent
Director TeramerauskaPresent
Principal Pappas CapitalPresent
Managing Director AbingworthPresent
Partner Takeda Ventures, Inc.Present
Co-founder Coho TherapeuticsPresent
Interim CEO HotmailPresent
Partner AbingworthPresent
UNC Kenan-Flagler Business School MBA Finance and Entrepreneurship
The College of New Jersey BS Biology, Chemistry Minor
University of Utah PhD Biology
Sign in with Google →
Sign in with Google →